UB Paderborn / Katalog / Suche / in CDI

Toxicity profile differences of adjuvant docetaxel/cyclophosphamide (TC) between Asian and Caucasian breast cancer patients

Asia-Pacific journal of clinical oncology, 2017-12, Vol.13 (6), p.372-378

2017

Link zum Volltext

Verfügbarkeit prüfen

P0164 Toxicity profiles of adjuvant docetaxel-cyclophosphamide in Asian compared with caucasian patients with breast cancer

European journal of cancer (1990), 2014-05, Vol.50, p.e55-e56

2014

Link zum Volltext

Verfügbarkeit prüfen

DNA hypermethylation of TIMP3 gene in invasive breast ductal carcinoma

Biomedicine & pharmacotherapy, 2005-10, Vol.59, p.S363-S365

2005

Link zum Volltext

Verfügbarkeit prüfen

135 Nuclear p53 protein and cell cytosol LDH expression as prognostic indicators to monitor FEC treatment in triple negative breast cancer

European journal of cancer supplements, 2010, Vol.8 (3), p.98-98

2010

Link zum Volltext

Verfügbarkeit prüfen

129 Down regulation of Heat Shock Protein 70 (HSP70) predicts responsiveness to neoadjuvant aromatase inhibitors in post-menopausal hormonal receptors expressing breast cancer

European journal of cancer supplements, 2010, Vol.8 (3), p.96-96

2010

Link zum Volltext

Verfügbarkeit prüfen

52 Bone metabolism and quality of life of postmenopausal women with invasive breast cancer receiving neoadjuvant hormonal therapy: sub-analyses from celecoxib anti-aromatase neoadjuvant (CAAN) trial

European journal of cancer supplements, 2010, Vol.8 (3), p.73-74

2010

Link zum Volltext

Verfügbarkeit prüfen

Immunomagnetic Tumor Cell Enrichment Is Promising in Detecting Circulating Breast Cancer Cells

Oncology, 2003-01, Vol.64 (2), p.160-165

2003

Link zum Volltext

Verfügbarkeit prüfen

Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil–epirubicin–cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to neoadjuvant chemotherapy

Breast cancer research and treatment, 2013-11, Vol.142 (1), p.69-80

2013

Link zum Volltext

Verfügbarkeit prüfen

A new predictive and prognostic marker (ATP bioluminescence and positron emission tomography) in vivo and in vitro for delivering adjuvant treatment plan to invasive breast tumor patients

Biomedicine & pharmacotherapy, 2006-07, Vol.60 (6), p.285-288

2006

Link zum Volltext

Verfügbarkeit prüfen

23P Expression Of Beta-Iii Tubulin, Foxo 3 Protein and Deoxythymidine Kinase in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

Annals of oncology, 2012-05, Vol.23, p.ii21

2012

Link zum Volltext

Verfügbarkeit prüfen

Multicenter phase 2 trial of varlitinib versus lapatinib in combination with capecitabine in patients with HER2+ metastatic breast cancer (MBC) who failed prior trastuzumab therapy

Annals of oncology, 2017-11, Vol.28, p.x30-x30

2017

Link zum Volltext

Verfügbarkeit prüfen

Predictions of the pathological response to neoadjuvant chemotherapy in patients with primary breast cancer using a data mining technique

Breast cancer research and treatment, 2012-07, Vol.134 (2), p.661-670

2012

Link zum Volltext

Verfügbarkeit prüfen

MR appearance of metastatic melanotic melanoma in the breast

Clinical radiology, 2000-07, Vol.55 (7), p.572-573

2000

Link zum Volltext

Verfügbarkeit prüfen

CLARITHROMYCIN ATTENUATES THE INFLAMMATORY RESPONSE INDUCED BY SURGICAL TRAUMA IN A GUINEA PIG MODEL

Pharmacological research, 1999-01, Vol.39 (1), p.49-54

1999

Link zum Volltext

Verfügbarkeit prüfen

Cyclooxygenase-2: possible predictor related to micrometastasis in breast cancer patients

Biomedicine & pharmacotherapy, 2005-10, Vol.59, p.S318-S318

2005

Link zum Volltext

Verfügbarkeit prüfen

Current directions for COX-2 inhibition in breast cancer

Biomedicine & pharmacotherapy, 2005-10, Vol.59, p.S281-S284

2005

Link zum Volltext

Verfügbarkeit prüfen

Fine needle aspiration is associated with hematogenous dissemination of breast cancer cells as determined by RT-PCR

European journal of cancer (1990), 1999-09, Vol.35, p.S88-S88

1999

Link zum Volltext

Verfügbarkeit prüfen

Increases in circulating VEGF levels during COX-2 inhibitor treatment in breast cancer patients

Biomedicine & pharmacotherapy, 2006-07, Vol.60 (6), p.277-279

2006

Link zum Volltext

Verfügbarkeit prüfen

Prognostic contribution of the HER-2 oncogene overexpression to the Nottingham Prognostic Index in breast cancer

Biomedicine & pharmacotherapy, 2006-07, Vol.60 (6), p.293-297

2006

Link zum Volltext

Verfügbarkeit prüfen

Translational research in oncology comes timely

Biomedicine & pharmacotherapy, 2005-10, Vol.59, p.S263-S263

2005

Link zum Volltext

Verfügbarkeit prüfen

57 Psychoneuroendocrine outcomes of psychosocial interventions for breast cancer patients in Hong Kong: Phase I results

Brain, behavior, and immunity, 2005-07, Vol.19 (4), p.e29-e30

2005

Link zum Volltext

Verfügbarkeit prüfen

Circulating tumor cells in patients with breast cancer: possible predictor of micro-metastasis in bone marrow but not in sentinel lymph nodes

Biomedicine & pharmacotherapy, 2005-10, Vol.59, p.S355-S358

2005

Link zum Volltext

Verfügbarkeit prüfen

Voltage-Gated K + Channels Promote BT-474 Breast Cancer Cell Migration

Journal of global oncology, 2018-10, Vol.4 (Supplement 2), p.192-192s

2018

Link zum Volltext

Verfügbarkeit prüfen

Serum lipid profiles in patients receiving endocrine treatment for breast cancer—the results from the Celecoxib Anti-Aromatase Neoadjuvant (CAAN) Trial

Biomedicine & pharmacotherapy, 2005-10, Vol.59, p.S302-S305

2005

Link zum Volltext

Verfügbarkeit prüfen

The efficacy of Paclitaxel on solid tumour analysed by ATP bioluminescence assay and VEGF expression: a translational research study

Biomedicine & pharmacotherapy, 2005-10, Vol.59, p.S337-S339

2005

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Toxicity profile differences of adjuvant docetaxel/cyclophosphamide (TC) between Asian and Caucasian breast cancer patients

P0164 Toxicity profiles of adjuvant docetaxel-cyclophosphamide in Asian compared with caucasian patients with breast cancer

DNA hypermethylation of TIMP3 gene in invasive breast ductal carcinoma

135 Nuclear p53 protein and cell cytosol LDH expression as prognostic indicators to monitor FEC treatment in triple negative breast cancer

129 Down regulation of Heat Shock Protein 70 (HSP70) predicts responsiveness to neoadjuvant aromatase inhibitors in post-menopausal hormonal receptors expressing breast cancer

52 Bone metabolism and quality of life of postmenopausal women with invasive breast cancer receiving neoadjuvant hormonal therapy: sub-analyses from celecoxib anti-aromatase neoadjuvant (CAAN) trial

Immunomagnetic Tumor Cell Enrichment Is Promising in Detecting Circulating Breast Cancer Cells

Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil–epirubicin–cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to neoadjuvant chemotherapy

A new predictive and prognostic marker (ATP bioluminescence and positron emission tomography) in vivo and in vitro for delivering adjuvant treatment plan to invasive breast tumor patients

23P Expression Of Beta-Iii Tubulin, Foxo 3 Protein and Deoxythymidine Kinase in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

Multicenter phase 2 trial of varlitinib versus lapatinib in combination with capecitabine in patients with HER2+ metastatic breast cancer (MBC) who failed prior trastuzumab therapy

Predictions of the pathological response to neoadjuvant chemotherapy in patients with primary breast cancer using a data mining technique

MR appearance of metastatic melanotic melanoma in the breast

CLARITHROMYCIN ATTENUATES THE INFLAMMATORY RESPONSE INDUCED BY SURGICAL TRAUMA IN A GUINEA PIG MODEL

Cyclooxygenase-2: possible predictor related to micrometastasis in breast cancer patients

Current directions for COX-2 inhibition in breast cancer

Fine needle aspiration is associated with hematogenous dissemination of breast cancer cells as determined by RT-PCR

Increases in circulating VEGF levels during COX-2 inhibitor treatment in breast cancer patients

Prognostic contribution of the HER-2 oncogene overexpression to the Nottingham Prognostic Index in breast cancer

Translational research in oncology comes timely

57 Psychoneuroendocrine outcomes of psychosocial interventions for breast cancer patients in Hong Kong: Phase I results

Circulating tumor cells in patients with breast cancer: possible predictor of micro-metastasis in bone marrow but not in sentinel lymph nodes

Voltage-Gated K + Channels Promote BT-474 Breast Cancer Cell Migration

Serum lipid profiles in patients receiving endocrine treatment for breast cancer—the results from the Celecoxib Anti-Aromatase Neoadjuvant (CAAN) Trial

The efficacy of Paclitaxel on solid tumour analysed by ATP bioluminescence assay and VEGF expression: a translational research study

Suchergebnisse filtern